MedCap AB (publ)

MedCap AB (publ) R&D per Employee

The R&D Spending per Employee of MedCap AB (publ) (MCAP.ST) as of Nov 22, 2026 is 200,696.86 SEK. In the previous year, R&D Spending per Employee was 154,006.97 SEK — a change of 30.32% (higher).

R&D per Employee

200,696.86SEK

YoY

30.32%

Last updated:

R&D Spending per Employee of MedCap AB (publ) is 2025 200,696.86 SEK. R&D Spending per Employee of MedCap AB (publ) was 2024 154,006.97 SEK. It decreases by 30.32% higher compared to the previous year.

The MedCap AB (publ) R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
101,045.30 SEK
Jan 1, 2019
108,710.80 SEK
Jan 1, 2020
69,337.98 SEK
Jan 1, 2021
70,034.84 SEK
Jan 1, 2022
118,466.90 SEK
Jan 1, 2023
50,522.65 SEK
Jan 1, 2024
154,006.97 SEK
Jan 1, 2025
200,696.86 SEK
The MedCap AB (publ) R&D per Employee history
YEARR&D per EmployeeYoY
200,696.86SEK+30.32%
154,006.97SEK+204.83%
50,522.65SEK-57.35%
118,466.90SEK+69.15%
70,034.84SEK+1.01%
69,337.98SEK-36.22%
108,710.80SEK+7.59%
101,045.30SEK+233.33%
30,313.59SEK-49.84%
60,432.06SEK+19.85%
50,421.60SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MedCap AB (publ) Stock analysis

What does MedCap AB (publ) do? MedCap AB (publ) is a Swedish company specializing in the development and marketing of medical products. The company was founded in 2006 by a group of experts in the medical industry. MedCap's business model is focused on developing and marketing innovative medical products. The company has two main business areas: Medical Devices and Diagnostics. In the Medical Devices area, MedCap develops products for various medical applications, including respiratory diseases, pain therapy, and wound care. In the Diagnostics area, the company offers diagnostic tests for various diseases, including infectious diseases and cancer. MedCap aims to improve medical care through innovative products. The company has introduced a range of groundbreaking products that offer higher effectiveness and more convenient use for patients. An example of a MedCap product is the Aeroneb® Pro. This is an advanced nebulizer device used for the treatment of respiratory diseases such as asthma, COPD, and cystic fibrosis. According to MedCap, the Aeroneb® Pro is the most effective nebulizer device of its kind, offering higher medication absorption through the lungs than other nebulizer devices. Another MedCap product is the ClipOn® Pain Relief. This is a portable pain reliever used to alleviate pain from various diseases such as arthritis and back pain. According to MedCap, the ClipOn® Pain Relief is a fast and safe way to relieve pain and improve patients' quality of life. In the Diagnostics area, MedCap offers a range of diagnostic tests for infectious diseases, including HIV, hepatitis, and tuberculosis. An example of a MedCap diagnostic test is the Diagnostics Quick Test (DQT), a rapid test for HIV detection. According to MedCap, the DQT is the fastest HIV test on the market, providing results in just 15 minutes. MedCap has also focused on the field of personalized medicine. The company has developed a platform called Confero that enables doctors to offer personalized medicine to their patients. Confero utilizes artificial intelligence and machine learning to provide accurate diagnosis and treatment for each patient. Overall, MedCap has established itself as a leading company in the medical industry, offering innovative products and services for medical care. The company has a strong presence in Europe and is also expanding into other parts of the world. MedCap aims to improve medical care through its products and services, making a positive impact on the lives of patients. MedCap AB (publ) is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MedCap AB (publ) stock

R&D Spending per Employee of MedCap AB (publ) is 200,696.86 SEK in 2025.

R&D Spending per Employee of MedCap AB (publ) changed from 154,006.97 SEK to 200,696.86 SEK, representing a 30.32% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee MedCap AB (publ) since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's MedCap AB (publ) historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — MedCap AB (publ)

All Key Metrics — MedCap AB (publ)